ClinVar Miner

Submissions for variant NM_003000.2(SDHB):c.32G>A (p.Arg11His) (rs111430410)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 8
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV000568010 SCV000675059 likely benign Hereditary cancer-predisposing syndrome 2017-09-27 criteria provided, single submitter clinical testing Lines of evidence used in support of classification: Other data supporting benign classification,In silico models in agreement (benign),Subpopulation frequency in support of benign classification
CSER_CC_NCGL; University of Washington Medical Center RCV000148868 SCV000190612 uncertain significance Renal cell carcinoma, papillary, 1 2014-06-01 no assertion criteria provided research
Counsyl RCV000662963 SCV000785936 likely benign Paragangliomas 4 2018-01-16 criteria provided, single submitter clinical testing
GeneDx RCV000607044 SCV000730538 likely benign not specified 2018-02-16 criteria provided, single submitter clinical testing This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.
Integrated Genetics/Laboratory Corporation of America RCV000607044 SCV000053116 likely benign not specified 2018-03-02 criteria provided, single submitter clinical testing Variant summary: SDHB c.32G>A (p.Arg11His) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00048 in 104928 control chromosomes. The observed variant frequency is approximately 544 fold of the estimated maximal expected allele frequency for a pathogenic variant in SDHB causing Pheochromocytoma phenotype (8.8e-07), strongly suggesting that the variant is benign. c.32G>A has been reported in the literature in individuals affected with eosinophilic chromophobe renal cell carcinoma. These report(s) do not provide unequivocal conclusions about association of the variant with Pheochromocytoma. One publication reports experimental evidence indicating positive SDHB immunostaining in tumors harboring this variant without concommitant pathogenic SDH-gene mutations. However, this does not allow convincing conclusions about the variant effect. Two clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as likely benign. Based on the evidence outlined above, the variant was classified as likely benign.
Invitae RCV000232749 SCV000287771 likely benign Gastrointestinal stroma tumor; Paragangliomas 4; Pheochromocytoma 2018-01-06 criteria provided, single submitter clinical testing
Mendelics RCV000708790 SCV000837739 uncertain significance Cowden syndrome 2018-07-02 criteria provided, single submitter clinical testing
Section on Medical Neuroendocrinolgy,National Institutes of Health RCV000505348 SCV000599482 pathogenic Hereditary Paraganglioma-Pheochromocytoma Syndromes no assertion criteria provided research

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.